Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science